Related Experiment Video
Updated: Jul 17, 2026
09:29
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
7.4K
Transcriptomics data integration and analysis to uncover hallmark genes in hypertrophic cardiomyopathy.
Peng Chen1, Warda Yawar2, Ayesha Rida Farooqui3
1Department of Cardiovascular Medicine, Taiyuan Central Hospital Taiyuan 030000, Shanxi, China.
American Journal of Translational Research
|March 11, 2024
Summary
This study identifies 8 key hub genes in hypertrophic cardiomyopathy (HCM) by analyzing gene expression data. These findings offer insights into HCM mechanisms and potential therapeutic targets.
Area of Science:
- Genomics
- Molecular Biology
- Cardiovascular Research
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex myocardial disease.
- Understanding the genetic underpinnings of HCM is crucial for effective treatment.
Purpose of the Study:
- To identify novel hypertrophic cardiomyopathy (HCM)-related hub genes.
- To explore the regulatory networks and potential therapeutic targets for HCM.
Main Methods:
- Differential gene expression analysis of public datasets (GSE68316, GSE36961).
- Identification and validation of hub genes using RNA-sequencing and bisulfite sequencing.
- Construction of lncRNA-miRNA-mRNA regulatory networks and pathway enrichment analysis.
Main Results:
- Eight key hub genes (5 upregulated, 3 downregulated) were identified and validated in clinical HCM samples.
- Regulatory networks involving 6 miRNAs and 4 lncRNAs associated with hub genes were elucidated.
- Hub genes were significantly enriched in pathways like Cardiac muscle contraction and Nitrogen metabolism.
Conclusions:
- The identified hub genes and their regulatory networks provide novel insights into HCM pathogenesis.
- These findings may facilitate the development of targeted therapies for hypertrophic cardiomyopathy.
